Alan Sebulsky, Director at Parabilis Medicines, Inc. (PBLS), bought 12,500 shares at $20.00 ($250K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Director Alan Sebulsky purchased $250,000 worth of PBLS stock at $20.00 per share, marking the largest insider purchase in the company's history. This substantial buyback signals insider confidence in the stock's valuation following recent volatility.
The stock recently closed at $27.26, down approximately 10% in a single session, though it previously soared following its Nasdaq debut. The insider purchase at $20.00 represents a discount to the recent $27.26 close.
The purchase represents the largest insider buy in the company's history, potentially signaling confidence in the stock's valuation.
The company reported a net loss of $209.706 million with no reported revenue, highlighting fundamental financial risks.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | BUY | 2009-11-17 | $67K | — | Filing → |
| JAZZ | BUY | 2007-06-08 | $90K | — | Filing → |
| ARRO | SELL | 2006-04-17 | $305K | — | Filing → |